View Zymeworks Inc. ZYME stock quote prices, financial information, real-time forecasts, and company news from CNN.

B. Riley Securities analyst initiated coverage with a Buy rating on Zymeworks today and set a price target of $40.00. Claim 55% Off TipRanks. Unlock powerful investing tools with ...

N-Zyme Biomedical press release "N-Zyme Biomedical Closes US$4.6 Million Series A Financing to Advance Clinical Development" ...

N-Zyme Biomedical today announced the successful closing of its Series A financing, raising approximately US$4.6 million to accelerate the advancement of its Phase 2 clinical programs and further the ...

Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced ...

Zymeworks Inc. (NASDAQ:ZYME) is one of the best small cap stocks to buy with the highest upside potential. Truist lifted the price target on Zymeworks Inc. (NASDAQ:ZYME) to $31 from $28 on July 7 and ...

Zymeworks has signed an agreement to acquire Theravance Biopharma in a cash transaction valued at approximately $929m.

Company advancing a first-in-class approach to targeting pepsin, with the potential to redefine the standard of care; recently granted patents from the U.S. Patent and Trademark Office and Japan ...

Zymeworks Inc. (ZYME) came out with a quarterly loss of $0.59 per share versus the Zacks Consensus Estimate of a loss of $0.1. This compares to a loss of $0.3 per share a year ago. These figures are ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...